Brain and spinal cord preconditioning for the protection against ischemic injury | Canada Hyperbarics Skip to main content
Review Masui 2007

Brain and spinal cord preconditioning for the protection against ischemic injury

Matsumoto M, Ishida K, Sakabe T — Masui, 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

This review summarized current research on brain and spinal cord preconditioning as a strategy to protect against ischaemic injury.

What They Found

Researchers found that preconditioning with volatile anesthetics like isoflurane and xenon showed strong neuroprotection in animal experiments. Additionally, erythropoietin, induced by hypoxic or pharmacological preconditioning, has demonstrated safety and benefit for acute stroke in humans, making it a promising neuroprotective agent.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a review, this study synthesizes existing research, much of which is based on animal experiments, and does not present new primary data.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 17366916
Year Published 2007
Journal Masui
MeSH Terms Anesthetics, Inhalation; Animals; Brain Ischemia; Erythropoietin; Humans; Hyperbaric Oxygenation; Ischemic Preconditioning, Myocardial; Neuroprotective Agents; Nitrous Oxide; Perioperative Care; Spinal Cord Ischemia; Xenon

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology